Skip to content
MS
unreviewed

Glucosylceramide synthase (UGCG)

1 reactions · 1 pathways

Cofactors used

What it does, reaction by reaction

1 reactions

Sphingolipid Synthesis Lipid Metabolism · ER + Golgi

step 6 Irreversible/directional

Ceramide + UDP-glucose -> glucosylceramide + UDP

Converts Ceramide UDP-glucose into Glucosylceramide UDP

› Notes

Entry to the glycosphingolipid/ganglioside series; sequential glycosyltransferases then build lactosylceramide, globosides and gangliosides.

Showing all 1 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

0 entries

No regulation recorded for this enzyme in the source documents.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Homocystinuria symptomatology collected through an international patient-report data program as a source for natural history data.

    Parke B, Bartke D, Beek G, Talebizadeh Z, Chapman KA, Baker J, Thomas JA. · 2026-09-11

    open access unreviewed
  2. 2
  3. 3
    Renal glycogen handling in diabetes: A narrative review of diabetic kidney disease pathogenesis.

    Ashok D, Manjrekar PA, Shetty BC, Sailet SS. · 2026-10-01

    open access unreviewed
  4. 4
  5. 5
  6. 6
    Single-Cell Transcriptomic Profiling Identifies B Cell-Intrinsic Dysregulation of Sphingolipid Biosynthesis and Could Be Improved by Inhibiting UGCG in Primary Immune Thrombocytopenia.

    Luo D, Zhan Y, Ji L, Xu P, Chen P, Pang H, Ling Y, Hua F, Zhuang X, Chen H, Cheng Y. · 2026-09-27

    open access unreviewed
  7. 7
    T-Cell Remodeling in Renal Fibrosis: From Acute Injury to Chronic Kidney Disease.

    Li Q, Guan J, Song Y, Yang H, Li G, Zhao X, Liu J, Liu B, Tan Y, Zhou H, Zhang YH, Wang Y. · 2026-09-27

    open access unreviewed
  8. 8
  9. 9
    Sphingolipid Remodeling and Extracellular Vesicle Signatures Reflect Disease Severity in Facioscapulohumeral Dystrophy Driven by Mitochondrial Dysfunction and Endoplasmic Reticulum Stress.

    Moriggi M, Ruggiero L, Torretta E, Zoppi D, Arosio B, Fiorillo C, Nigro V, Capitanio D, Gelfi C. · 2026-09-14

    open access unreviewed
  10. 10

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.